Opportunity Information:
Apply for W81XWH 21 OCRP OCA
- The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "CDMRP Ovarian Cancer, Ovarian Cancer Academy Award" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
- This funding opportunity was created on Feb 08, 2021.
- Applicants must submit their applications by Jul 08, 2021.
- The number of recipients for this funding is limited to 2 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
Browse more opportunities from the same category: Science and Technology and other Research and Development
Next opportunity: Jail to Community Reentry Initiative (JCRI)
Previous opportunity: Civil Service Leadership Training for the Future
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for W81XWH 21 OCRP OCA
Applicants also applied for:
Applicants who have applied for this opportunity (W81XWH 21 OCRP OCA) also looked into and applied for these:
Funding Number | Funding Title |
---|---|
W81XWH 21 OCRP PGRA | CDMRP Ovarian Cancer Proteogenomics Research Award |
21 560 | Understanding the Rules of Life: Emergent Networks |
W81XWH 21 LCRP CDA | DoD Lung Cancer, Career Development Award |
W81XWH 21 LCRP CA | DoD Lung Cancer, Concept Award |
W81EWF 21 SOI 0009 | Field Experiments for Chemical Control of Starry Stonewort (Nitellopsis obtusa) |
W81EWF 21 SOI 0008 | Monitoring Ecological Parameters in the Forested Wetlands of Southern Florida |
21 561 | Stimulating Collaborative Advances Leveraging Expertise in the Mathematical and Scientific Foundations of Deep Learning |
W81XWH 21 ALSRP TIA | DoD Amyotrophic Lateral Sclerosis, Therapeutic Idea Award |
W81XWH 21 ALSRP TDA | DoD Amyotrophic Lateral Sclerosis, Therapeutic Development Award |
W81XWH 21 ALSRP TBPTA | DoD Amyotrophic Lateral Sclerosis, Therapeutic/Biomarker Pilot Trial Award |
W81XWH 21 ALSRP CDA | DoD Amyotrophic Lateral Sclerosis, Clinical Development Award |
USAFA BAA 2021 CALL 0001 | Developing Novel Engineering Design Methodologies for the Classroom, the Department of Defense, and Industry |
HHS 2021 ACL NIDILRR REGE 0030 | Rehabilitation Engineering Research Centers (RERC) Program: RERC on Blindness and Low Vision |
HHS 2021 ACL NIDILRR RTCP 0028 | Rehabilitation Research and Training Center (RRTC) on Interventions to Promote Community Living Among People with Disabilities. |
PAS MTY 2021 01 | Public diplomacy grant program – Empowering communities through technology and education |
N00014 21 S SN07 | 2021 London Tech Bridge Research Opportunity |
W81XWH 21 DMRDP ERCA | Defense Medical Research and Development Program - En Route Care Award |
HHS 2021 ACL NIDILRR REGE 0029 | Rehabilitation Engineering Research Centers (RERC) Program: RERC on Wireless Technologies |
W9126G 21 2 SOI 2409 | Maneuver Damage Support, Fort Polk |
2021 NIST JQI QUICS 01 | NIST Joint Quantum Institute (JQI) and Joint Center for Quantum Information in Computer Science (QuICS) Institutional Cooperative Agreements Renewal |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 21 OCRP OCA", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.